newsfilter
← Latest News
GlobeNewswire·

CENTOGENE to Participate in Upcoming Conferences in February in the Lead Up to Rare Disease Day

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (NASDAQ:CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today